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ABSTRACT 
 
There is a wide, unexplained variation in treatment and results for specific medical 
conditions. Health systems development clinical pathways to reduce clinical variation, improve 
quality, which ultimately leads to lower cost of healthcare. Much research has already been done 
to determine best practices for developing clinical pathways, but data supporting the true 
effectiveness of clinical pathways on reducing variation to improve patient outcomes by 
providing the appropriate care is limited. The development of robust clinical pathway data 
analytics will benefit beyond the health systems and have a public health significance by 
improving quality, reducing clinical variation to provide the most appropriate clinical care, and 
increasing the understanding and treatment of high-risk disease trends. This paper will focus on 
the best practices for developing and implementing clinical pathways, and discuss clinical 
outcome reporting findings and data limitations that should be considered.   
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1.0  INTRODUCTION 
As both private and public efforts to reform the U.S. healthcare system gain momentum, it is 
clear that innovation must encompass more than just new medical devices or products. Health 
care innovation needs to explore new areas, including value based reimbursement, care model 
design, data analytics, patient engagement, and provider incentives. 
Examining clinical variation in medical practice is an important step to measuring 
efficiency and effectiveness in care delivery. Due to unique patient preferences and care-setting 
characteristics, there will always be a degree of appropriate variation in the practice of medicine, 
even for patients with the same diagnoses. It is clear, however, that through the use of evidence-
based and data-based approaches to clinical decision-making, hospitals and providers across the 
country can do much more to reduce inappropriate or unwarranted variation.  
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2.0  HEALTH CARE REFORM 
President Obama enacted the Affordable Care in 2010 with the goals of increasing the quality 
and affordability of health insurance, lowering the uninsured rate by expanding public and 
private insurance coverage, and reducing the costs of healthcare for individuals and the 
government. Healthcare spending in the United States has gradually spiraled out of control, and 
accounts for 17.5 percent of the gross domestic product (Davis, Stremikis, Squires, & and 
Schoen, 2014). A 2007 study by the American Journal of Medicine found approximately 62 
percent of all personal bankruptcies in the United States were related to medical bills. Even more 
alarming, 78 percent of those involved had health insurance and were bankrupted due to gaps in 
coverage (co-payments, deductibles, uncovered services, etc.)  (Himmelstein, Thorne, Warren, & 
Woolhandler, 2009).  
The United States also ranks behind most countries on many measures of health 
outcomes, quality, and efficiency (Davis, Stremikis, Squires, & and Schoen, 2014). Physicians in 
the Unites States face particular difficulties receiving timely information, coordinating care, and 
dealing with administrative hassles. Numerous countries outside of the United States have 
succeeded in the adoption of modern health information systems, but U.S. physicians and 
hospitals are still playing catch-up in many regards as they respond to financial incentives to 
adopt and make meaningful use of multiple health information technology systems.  
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Additional provisions in the Affordable Care Act have encouraged organizations to find 
innovative ways to efficiently delivery of health care, as well as investment in important 
preventive and population health measures. As the focus shifts from filling hospital beds and 
keeping volumes high to keeping patients healthy and out of the hospital, the culture of 
healthcare delivery will be forced to change in order to meet these new initiatives.   
As healthcare payers and providers seek to transition to new, value-based payment 
models, clinical pathways are one strategy used to fulfill the goals of the Affordable Care Act 
and promote appropriate, evidence-based care. 
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3.0  CLINICAL PATHWAYS 
As the Affordable Care Act continues to gain momentum, health systems are forced to adopt new 
models to provide patients with the highest quality of clinical care. Many health systems are 
turning to clinical pathways as a way to analyze costs, reduce variation, and improve clinical 
quality.  However, the basic concept of clinical pathways is not a new phenomenon in healthcare 
today.  Clinical Pathways were introduced in the early 1990s in the UK and the USA, but 
adoption of pathways has increased as the over utilization of low value services has led to high 
variation and increased costs. This trend has encouraged healthcare systems to look for 
innovative ways to provide high quality, appropriate clinical care to patients in a cost effective 
way (OpenClinical, 2005). Clinical Pathways provide detailed guidance for each stage in the 
management of a patient, such as treatments and interventions, with a specific condition over a 
given time period. Additionally, the implementation of the Electronic Medical Record (EMR) 
has improved the data analytic pathway reporting capabilities. 
This next section will identify best practices identified through a review of the literature, 
as well as the current clinical pathway development and implementation process that is used by 
the University of Pittsburgh Medical Center (UPMC).     
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3.1 DEFINITION 
Three recent articles provide a strong foundation for the modern perception of Clinical Pathways 
and key points are summarized in Table 1.  
The following five criteria were derived from these three sentinel articles: (1) the 
intervention was a structured multidisciplinary plan of care (Campbell HHR, 1998); (2) the 
intervention was used to channel the translation of guidelines or evidence into local structures 
(Campbell HHR, 1998); (3) the intervention detailed the steps in a course of treatment or care in 
a plan, pathway, algorithm, guideline, or protocol (De Bleser, et al., 2006); (4) the intervention 
had timeframes or a criteria-based progression (De Bleser, et al., 2006); and (5) the intervention 
aimed to standardize care for a specific clinical problem, procedure or episode of healthcare in a 
specific population (Vanhaecht K, 2006).  
(Source: What is a Clinical Pathway? Kinsman, Rotter, James, Snow, & Willis, 2010) 
 
The overall purpose of clinical pathways are to improve outcomes by providing a mechanism to 
coordinate care, reduce fragmentation, and increase the use of appropriate medical testing, 
Table 1. Characteristics of Clinical Pathways Derived from Sentinel Articles 
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medications, and procedures. Clinical Pathways differ from practice guidelines, protocols, and 
algorithms as they are utilized by a multidisciplinary team and have a focus on the quality and 
coordination of care (OpenClinical, 2005). Reducing the amount of unnecessary, non-value 
adding inappropriate clinical care will contribute to the overall cost reduction of healthcare. 
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3.2 DEVELOPMENT 
Successful development of a new clinical pathway, or adaptation of a currently existing clinical 
pathway, requires the formation of a group that will develop, implement and evaluate the 
proposed Clinical Pathway. Figure 1 illustrates the clinical pathway management workflow at 
UPMC.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: UPMC Chief Medical and Scientific Office, 2016 
 
 
Figure 1. UPMC Pathway Development Process 
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The Pathway Executive Committee manages all of the clinical pathways for the entire 
system, but anyone (usually physician led) can propose a request for a new clinical pathway. 
High-volume, problem-prone or high-risk issues serve as the keys to identifying the focus of 
need for clinical pathways. Clinical areas with poor health outcomes and low quality scores may 
also be examined. Similarly, the dynamics of cost and/or physician or payer interest may help 
isolate the issue to be addressed. UPMC aims to implement pathways that will improve quality 
by providing the appropriate intervention and reducing clinical variation, affect a large number 
of patients, which downstream effects should reduce the total cost of care for hospitals and 
patients. If the disease specific area falls into one of those three buckets, the pathway will most 
likely be accepted.  
When forming a Clinical Pathway development group (local pathway ream), it is 
important to think about the various clinical roles that will be affected by the introduction of the 
pathway. The pathway team usually beings by engaging physicians, but it is important to also 
obtain the perspective and expertise of nurses, pharmacists, therapists, and any other key 
components of the care team. Each local pathway team will have a slightly different makeup, and 
it is critical to engage the appropriate people based on the scope of the proposed clinical 
pathway. 
 It is important to consider the necessary tasks that the group will need to complete to 
implement the pathway and all of the skills required for the project such as data collection, 
outcome analysis, training, and continuous education. For example, the local pathway team for a 
UPMC Foot and Ankle surgery pathway will have a different composition than the Acute Kidney 
Infection (AKI) pathway team. Due to the surgical nature, the first step in identifying the 
pathway focus started with the surgical supply cost. The financial analyst pulled the supply costs 
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for employed and non-employed physicians that performed surgery at a UPMC hospital. This 
created the starting point for discussion when the pathway team was trying to determine the 
appropriate coding, supply use, and clinical procedures.  In contrast, the AKI pathway team at 
was comprised solely of employed physicians within the department of Renal-Nephrology. The 
objective of the AKI pathway was to determine the appropriate criteria for recognizing and 
diagnosing AKI since creatinine ratios is a highly disputed topic between nephrologists. For the 
scope of this pathway, there was no need to include a financial analyst on the AKI local pathway 
team.  
In addition to determining whether to include data and financial analysts in the pathway 
team, equal consideration should be given to the inclusion of certain physicians and 
administrators within the care spectrum. In a health system as large as UPMC, local pathway 
teams should aim to obtain buy-in from colleagues from the urban academic setting, community 
setting, and even some key private physician groups that have a strong presence in a UPMC 
facility.  It is important to closely examine the areas within the care continuum that the proposed 
pathway may affect. Some clinical pathways may span more than one disease area or specialty. 
The local pathway team should always try to engage physicians and where appropriate, some key 
administrators, to represent each clinical area within the pathway to ensure buy-in.  
3.3 IMPLEMENTATION 
Computerized physician order entry (CPOE) is defined by the Healthcare Information and 
Management Systems Society (HIMSS) dictionary as an "order entry application specifically 
designed to assist clinical practitioners in creating and managing medical orders for patient 
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services and medications" (HIMSS, 2010).  The CPOE is an electronic medical 
record technology that allows physicians to enter orders, medications, or procedures directly into 
the computer instead of handwriting them (HIMSS, 2010).  Traditionally, physicians would enter 
orders, medications, and procedures by writing them on a piece of paper, however many 
institutions have switched to the electronic medical record started to enter these orders through 
the use of an “order set”. An order set is a group of related orders, and can be general or disease 
specific. One of the benefits to using an order set is that it allows users to issue “prepackaged 
groups of orders that apply to a specified diagnosis or a particular period of time,” which 
ultimately reduces the time that the physician spends finding and entering the specified orders 
(Franklin et.al, 1998).  
UPMC uses the CPOE in Cerner in all of its inpatient facilities, and each inpatient 
clinical pathway algorithm developed at UPMC is turned into a PowerPlan. A PowerPlan is very 
similar to an order set, and can include multiple phases. Some of the key benefits of PowerPlan 
usage include improved care quality and patient safety through interdisciplinary planning by use 
of a phased approach to patient care based on organizational standards (Cerner, 2014).  
It is important to establish a timeframe for implementation with the intent that the 
pathway team meets frequently during the initial months to allow for feedback and discussion.  
Before the pathway can be rolled out to all sites, an initial pilot site should be determined for the 
first round of “go-live”. Once the local pathway team has developed the clinical content, the 
pathway algorithm is integrated into Cerner and turned into a PowerPlan. Training sessions are 
held at each site before go-live to ensure that all end-users are aware of the pathway are educated 
on the benefits and technical components of using the pathway and accessing the PowerPlan.  
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3.3.1 Barriers and Facilitators to Implementation 
Some physicians have embraced the use of clinical pathways, while others have resisted. One of 
the most common responses from physicians when asked about their resistance to clinical 
pathways say it's too much of a “cookie-cutter approach” to practicing medicine (Gisme & 
Wiseman. 2011). In a 2011 Journal of Oncology Practice article, Dr. Bruce A. Feinberg, Vice 
President and Chief Medical Officer of P4 Healthcare, quoted: 
“I always derived my greatest satisfaction from making the diagnosis, managing toxicity, 
and managing patient care throughout the process. That's where the art of medicine is—
not in selecting which three-drug combination I'm going to prescribe” (Gisme & 
Wiseman. 2011). 
 
A survey of thirty-two UPMC physicians in 2014 revealed that the top three most significant 
barriers to successful implantation of clinical pathways were engagement of providers, 
integrating the pathway into the workflow and care of the patient, and resistance to changing 
clinical practice. Although the local pathway teams are predominately physician led, it is critical 
to engage providers and obtain input from physicians at all sites and not just ones within the 
academic medicine setting. It is extremely common for variation of clinical practice to occur 
between physician groups in addition to urban and community hospital setting. Furthermore, 
many physicians create their own customized order sets and pick and choose the orders they 
need for treating a patient. It was reported that the layout and location of the PowerPlan was not 
conducive to their workflow. The purpose of a clinical pathway and PowerPlan is to streamline 
the process for treating disease specific conditions, but lack of provider PowerPlan training and 
education make some physicians revert back to using order sets because they feel more 
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comfortable and can access more quickly. The most important factor identified as integral to 
adherence and successful implementation was leadership from the Chair/Departmental level.  
 When asked their opinions and suggestions for accelerating physician led developments 
of pathways across all major disease and procedure areas, many physicians said that there needed 
to be a change in the compensation model. Consequently, the data shows that the pathways that 
are tied to compensation have the highest utilization. Total Joint Replacement and Spine Fusion 
Surgery pathways have two of the highest utilization levels, and both are tied to bundled 
payments and shared savings programs. The UPMC Department of Surgery has already started to 
include pathway utilization in physician incentive plans, and effects of this inclusion can be seen 
in Figure 2. 
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Source: UPMC Chief Medical and Scientific Office, 2016 
Figure 2. Pathway Utilization, May 2015-December 2015 
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3.4 INPATIENT PATHWAY UTILIZATION 
Inpatient pathway utilization is calculated by the total number of times the physician 
appropriately initiated the PowerPlan for a patient, divided by the total number of patients within 
that population in which the PowerPlan should have been initiated. For example, if a patient 
presents to the hospital with COPD, the attending physician should initiate the COPD PowerPlan 
on that patient. If the physician sees ten patients with COPD but only initiates the PowerPlan on 
five of those patients, the physician’s COPD pathway utilization would be 50%. However, this 
calculation does not exclude instances where the physician launches the PowerPlan but does not 
actually use it. The physician can open the PowerPlan and immediately close out, and it would 
still count positively towards the overall pathway utilization.  
The goal of pathway utilization should never be 100%, and should allow for some degree 
of variability. The pathway will never be appropriate for 100% of the patient population due to 
complications and cofounding conditions. To account for this expected degree of variation, we 
based our recommendation of expected pathway usage on the “80/20 Pareto Rule” and set the 
pathway utilization goal at 80%.  
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4.0  OUTCOME REPORTING 
One of the most important steps to implementing a new project or intervention is developing the 
criteria that will be used to evaluate the overall progress and effectiveness of the intervention.  
The first step to developing outcome reporting for clinical pathways is to determine the patient 
population definition. The definition serves as the denominator for utilization statistics and is 
also used to pull outcome metrics.  Some pathways definitions can be defined by current clinical 
guidelines; some surgical pathways such as Total Joint Replacement were defined based on CMS 
definition; and other medical pathways can be defined by a combination of physician clinical 
expertise and personnel experienced with billing and coding. It is important to remember that the 
clinical pathway is not designed to treat 100% of the patients that initially present with the 
specified diagnosis or procedure.  The definition should not be all-encompassing and should not 
try to capture patients that may be a clinical outlier for which the pathway may not apply.  
 Each local pathway team at UPMC developed a set of outcome metrics, and the Pathway 
Executive Committee created a reporting package for each individual pathway. In addition, the 
Executive Committee also created a core outcome executive summary reporting dashboard that 
displayed utilization, 30-day readmission, length of stay, and length of stay in the Intensive Care 
Unit (ICU). Baseline period for all pathways was defined as twelve months prior to pathway go-
live. Period 1 was defined as pathway go-live through April 2015, so Period 1 varies slightly 
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between pathways. Period 2 was defined as May 2015 through September 2015, and Period 3 
was defined as October 2015 through December 2015 for all clinical pathways. 
 The clinical pathway outcome reporting process at UPMC was developed largely through 
trial and error. Through this process, the main areas of concern that emerged were:  
1. The conversion mapping of ICD-9 codes to ICD-10 
2. Access to granular data to compare outcomes of patients on pathway vs. off pathway 
3. Limited availability of cost data to determine cost-effectiveness of each pathway 
4. Determining the success of clinical pathways when utilization was low 
4.1 THE CONVERSION FROM ICD-9 TO ICD-10 
Prior to October 1, 2015, most clinical pathways were defined by a particular set of ICD-9 codes, 
procedure codes (CPT), a Diagnosis-Related Group code (DRG), or some combination of the 
three. That method of classification and coding changed dramatically on October 1, 2015 when 
ICD-10 coding was implemented in all HIPPA-covered entities. In June 2015, Centers for 
Medicare and Medicaid Services (CMS) released the following statement in regards to this 
change: 
ICD-10-CM will replace ICD-9-CM diagnosis codes in all health care settings for 
diagnosis reporting with dates of service, or dates of discharge for inpatients, that occur 
on or after October 1, 2015. ICD-10-PCS will replace ICD-9-CM procedure codes (CMS, 
2015). 
CMS provided a mapping document that serves as a cross-walk for ICD-9 and ICD-10 
conversions. Since the electronic medical record and many other reporting systems no longer 
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recognize ICD-9 codes, the mapping document is the only way to compare a population from pre 
and post conversion. 
4.1.1 Benefits of the ICD-10 Conversion 
CMS reported that the implementation of ICD-10-CM and -PCS will ultimately result in a 
“lower coding error rate than ICD-9-CM” and fewer erroneous and rejected reimbursement 
claims because ICD-10 codes are “less ambiguous” and more “logically organized and detailed” 
(CMS, 2015). In a perfect world, the increased specificity of codes will make it easier to 
compare reported codes with clinical documentation, check for consistency between diagnosis 
and procedure codes, and check for illogical combinations of diagnoses (Bowman, 2008). The 
use of ICD-10-CM and –PCS, if used correctly, may also improve fraud detection capabilities. 
Additionally, increased specificity of detail may lead to a better justification of medical 
necessity. Although cumbersome to primary users, U.S. public health officials at the federal, 
state, and local level rely on the receipt of ICD-9-CM (and now ICD-10) coded data from 
HIPAA-covered entities to conduct many disease-related reports. From a public health 
perspective, this change in coding will hopefully provide better data for measuring care furnished 
to patients, designing payment systems and processing claims, tracking public-health, and 
conducting research (CMS, 2015). 
 In summary, the increased specificity of codes should allow physicians to improve the 
accuracy of clinical pathway definitions and provide higher quality of care to the most 
appropriate population.  
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4.1.2 Disadvantages of the ICD-10 Conversion  
An increased number of codes to choose from can lead to an increased amount of confusion by 
physicians, billing and coding specialists, and data analysts. There is not a 1:1 ratio of ICD-9 
codes to ICD-10 codes.  Currently, there are 68,000 ICD-10-CM codes and 87,000 ICD-10-PCS 
codes; compared to 14,000 ICD-9-CM codes and 4,000 ICD-9-PCS codes available (CMS, 
2015). The complicity of data inaccuracy occurs when an ICD-9 defined population is compared 
over a period of time that includes data from before and after October 1, 2015.  
For example, the Total Joint Replacement pathway had previously been defined by two 
ICD-9 procedure codes: 81.51, 81.54. After the conversion, codes 81.51 and 81.54 mapped to 
twenty-four ICD-10 procedure codes. The Geriatric Hip Fracture pathway was defined by eight 
ICD-9 diagnosis codes and five ICD-9 procedure codes. Post conversion, the original eight 
diagnosis codes mapped to eleven ICD-10 diagnosis codes, and the five original procedure codes 
mapped to ninety-five ICD-10 procedure codes. The Seizure pathway also experienced a 
substantial bump in the number of codes, increasing from twenty-four ICD-9 codes to fifty-two 
ICD-10 codes. 
The conversion to ICD-10 coding also identified areas where some conditions may have 
been improperly coded, or if not coded improperly, were coded differently than what the ICD-9 
pathway definition had originally included. An example of this discrepancy occurred in the 
Stroke pathway, and is shown in Figure 3. Even at measuring just three months of data, Period 3 
is significantly lower than what would be expected based on historical volumes from Periods 1 
and 2. ICD-9 to ICD-10 crosswalk was verified and no human error was found in the conversion 
process. In order to determine the root cause of the volume discrepancy, a chart review is 
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recommended to gain an understanding of how stroke patients are being identified post ICD-10 
conversion. 
 
 
 
 
 
 
 
 
 
 
4.2 OUTCOMES OF PATIENTS ON PATHWAY VS. OFF PATHWAY 
One of the limitations of the data is that it does not portray the clinical outcomes of patients 
treated on the pathway versus off of the pathway. In this scenario, the data we collected shows 
the outcome metrics of a disease specific population over a specified period of time. Pathway 
utilization is not the driver of these metrics, but only an additional outcome metric in itself. Our 
current reporting capabilities do not compare the outcomes of patients that were treated by using 
Source: UPMC Chief Medical and Scientific Office, 2016 
Figure 3. Stroke Pathway Utilization 
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the pathway, compared to patients that were treated off the pathway. In order to truly assess the 
viability of the clinical pathway, a like-population would need to be identified and compared to 
outcomes of like patients treated on the pathway. Comparing outcomes of patients treated on 
pathway vs. off pathway is the most accurate way to determine whether or not the intervention is 
truly most effective.  This type of data is necessary to evaluate the effectiveness, both quality and 
cost, of each decision point within the pathway. The granular level of data could be achieved 
manually through abstract and chart review, but it is very time and resource intensive. 
Furthermore, once sub-groups within the pathway were identified to assess outcomes of each 
clinical decision point, the sample size becomes extremely small. Clinical pathways aim to 
provide physicians with a tool to guide them through administering the most appropriate care 
based on evidence and best practice. Access to granular order data is needed in order to evaluate 
outcomes associated with each decision point within the pathway. 
4.3 LIMITED ACCESS TO COST DATA 
A cost accounting system is a system for recording, analyzing, and allocating cost to the 
individual services provided to patients such as medications, procedures, tests, and hospital room 
and board. Like many United States health systems, UPMC is currently in the process of 
developing a sophisticated cost accounting system that will correlate the cost of care with 
individual quality outcomes. Clinical pathways aim to improve quality of care by reducing 
clinical variation. If implemented and adopted successfully, the decrease in over-utilization of 
low value services should lead to a reduction in the overall cost of healthcare.  
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 Current availability of the cost accounting data is limited. Estimates based on claims 
payments and historical cost averages can be used as place holders, but those numbers are not 
entirely accurate and should not be used when trying to determine the true cost-effectiveness of 
decision points within the pathway. Once the cost accounting system is available, analysts should 
be able to determine the total cost of a patient treated using the pathway compared to a patient 
not treated on the pathway. Further analysis should examine the cost of each decision point 
within the pathway, and when correlated to each decision point’s quality outcomes, will provide 
physicians with a true cost effective analysis of the clinical pathway. This level of detailed 
analysis is required in order to provide physicians with meaningful data and actionable feedback. 
4.4 IMPROVING CLINICAL OUTCOMES 
Success of the pathway should not be measured by utilization alone. Figure 4 illustrates the 
Acute Pancreatitis Pathway outcomes. Utilization of this pathway is extremely low at 5%, but all 
metrics are trending in the desired direction. If a pathway only has 5% utilization but clinical 
outcomes are trending in the desired direction, can one still make the conclusion that the pathway 
is working? If we measure success of a pathway by the ability to improve the health outcome of 
the population, then the Acute Pancreatitis Pathway should be viewed as a success. Clinical 
pathways establish outcome metrics to measure impact and effectiveness of the implementation. 
Comparing these metrics to the baseline period prior to implementation and after shows the 
change that the intervention had on the population.   
UPMC physicians identified PowerPlans as being a burden to workflows and that it was 
more convenient to use their own customized order sets. However, a customized order set could 
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potentially look almost identical to a clinical pathway PowerPlan; further data mining should 
occur  to determine whether the customized order sets contain similar labs, tests, and medications 
as the disease specific PowerPlan. As discussed previously, it is imperative to identify the actual 
orders that are being used and the outcomes associated with those orders. 
Additionally, there are many external factors that are not captured in a clinical pathway 
that still may impact the overall outcome of the pathway. Factors such as training, education, and 
organizational initiatives such as hand washing may impact some of the metrics captured in 
clinical pathway reporting.  
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Source: UPMC Chief Medical and Scientific Office, 2016 
Figure 4. Acute Pancreatitis Pathway Outcomes 
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5.0  CONCLUSION 
Provider engagement is key to successful implementation. In a large health system, it is 
crucial to have input from multiple provider groups even within the same specialty, because best 
practices can vary. Clinical Pathway utilization is low in instances where they are not tied to 
payment incentives, but further analytics need to occur in order to justify the use of clinical 
pathways over other care models.  
Additional reporting capabilities need to be implemented in order to truly assess the 
impact that pathways have on the health system. An essential part of the clinical pathway process 
is the collection and analysis of information for when patient care deviates from the pathway. 
Not all patients are appropriate candidates for pathway use, but an analysis of variation provides 
useful and accurate information on the frequency and causes of variation and deviation from the 
pathway. Not all deviation and variation is bad, but it is important understand the root cause and 
reasoning behind the variation. In order for providers to administer the most appropriate care, an 
analysis must be done on each decision point within the pathway to determine the outcomes 
associated with each decision.  
Complications associated with the ICD-10 conversion contributed to inaccuracies in 
coding some clinical pathway definitions. The current outcome reporting mechanisms assesses 
the outcome of the pathway as a whole. In the current state of outcome reporting, it is difficult to 
determine where a change should be made since the outcomes are reported as the sum total of all 
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pathway decisions. The development of a sophisticated cost accounting system will allow 
physicians to view the correlation between quality outcomes and cost of care provided. This 
mechanism should be used to review each order within a pathway, and can be used as evidence 
to support clinical decisions within the pathway.  
Overall, clinical pathways aim to improve quality by reducing clinical variation and 
providing the patient with the most appropriate orders, labs, tests, and medications. Clinical 
pathways aim to decrease the over utilization of low value care which is usually costly and not 
medically beneficial to the health system or patient. Outcome reporting is an essential step in the 
clinical pathway process, and detailed analytics is necessary to develop meaningful feedback to 
the physicians and care teams. Further analysis of granular data at the individual order level is 
still needed to determine the true success of the intervention and to identify improvement 
opportunities within each clinical pathway.  
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